Ed McDermott | Managing Director, UK EMMAC Life Sciences Group With a reported 1.4 million people in the UK accessing cannabis illegally to self-medicate a diagnosed medical condition, it is clear that for many patients, the black market has remained a necessary port of call for them to access their ‘medicine’. Whilst fraught with not only a question of compromised morals, but also very real concerns regarding product quality and personal safety to access, it appears that the new legal framework, allowing access to medical cannabis on prescription, has still not been a viable option for many. At